Treating Alzheimer’s Very Early Offers Better Hope of Slowing Decline, Study Finds

A trial of donanemab, an experimental drug, found it modestly slowed the worsening of memory and thinking and worked better in patients at earlier stages and those under 75.

PAM BELLUCK
Author: PAM BELLUCK

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.